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 Abstract
Objective: The tumor suppressor p53 regulates cell proliferation and apoptosis, two key processes in the pathogenesis of occlusive vascular
disease. Here, we examined the consequences of heightening p53 function on neointimal lesion formation in the setting of atherosclerosis and
mechanical injury.
Methods: For this study we employed immunohistopathological characterization of neointimal lesions in atherosclerosis-prone
apolipoprotein E-null mice with normal p53 gene dosage (apoE-KO) and carrying a p53 transgene (Super-p53/apoE-KO). We also carried
out molecular studies in macrophages and smooth muscle cells (SMCs) obtained from these mice.
Results: The p53 transgene conferred p53 gain-of-function in cultured cells and mice. In vitro, survival of irradiated Super-p53 macrophages
and femoral SMCs was reduced, but only Super-p53 SMCs exhibited attenuated proliferation. In vivo, whereas the size of spontaneously
formed and diet-induced aortic atheromas was indistinguishable in apoE-KO and Super-p53/apoE-KO mice, the latter exhibited attenuated
neointimal thickening in mechanically injured femoral artery. In both models, neither apoptosis nor cell proliferation were affected by
additional p53 gene dosage when examined in established neointimal lesions. However, at 2 days after mechanical injury when neointimal
lesions were not yet formed, cell proliferation was significantly attenuated within medial SMCs of Super-p53/apoE-KO mice.
Conclusion: Heightening p53 function has differential effects on in vitro proliferation of macrophages (unaffected) versus SMCs (reduced),
and on native atherosclerosis (unaffected) versusmechanically induced neointimal thickening (reduced) in apoE-KOmice. The protective effect
of p53 in mechanically injured femoral artery coincided with limited medial SMC proliferation at early time points preceding neointima
formation, but neither medial nor neointimal cell proliferation was affected in vessels with established occlusive lesions. These findings
corroborate p53 gain-of-function as a promising therapeutic strategy to limit post-angioplasty restenosis but not native atherosclerosis.
© 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.Keywords: Atherosclerosis; Restenosis; p53; Genetically modified mice⁎ Corresponding author. Instituto de Biomedicina de Valencia, Jaime Roig
11, 46010 Valencia, Spain. Tel.: +34 963391752; fax: +34 963391751.
E-mail address: vandres@ibv.csic.es (V. Andrés).
0008-6363/$ - see front matter © 2007 European Society of Cardiology. Publishe
doi:10.1016/j.cardiores.2007.05.0021. Introduction
Atherosclerosis and restenosis are multifactorial process-
es involving complex interactions among diverse cell types
[1–4]. In both diseases, excessive proliferation of vasculard by Elsevier B.V. All rights reserved.
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 SMCs, macrophages and adventitial myofibroblasts contrib-
utes to neointimal lesion development and diminished vas-
cular patency [5–7]. Vascular cell loss by apoptotic death,
which has been documented in animal and human athero-
sclerosis and restenosis, also appears to be a major deter-
minant of the size and stability of neointimal lesions [8].
Therefore, unraveling the molecular mechanisms that control
neointimal cell growth and apoptosis is of utmost importance
to identify therapeutic targets to limit neointimal thickening
and prevent plaque rupture.
The tumor suppressor gene p53 is expressed ubiquitously
in all cell types as an inactive, latent, transcription factor
which undergoes activation in response to a variety of cellular
insults, namely DNA damage (signaled through the ATM and
Chk kinases) and oncogenic stress (signaled through the p53-
stabilizing protein ARF) [9]. Transcriptionally active p53
participates in the expression of pro-apoptotic (e.g., Bax, Fas,
PUMA) and anti-proliferative (e.g., p21Cip1, GADD45)
genes, and in the repression of anti-apoptotic (eg, bcl-2)
and pro-proliferative (eg, IGF-II) genes. Whether p53
activation provokes apoptosis or growth arrest, either
reversible or permanent (replicative senescence), depends
on the context and cellular type. Mounting evidence has
implicated p53 as a critical regulator of pathological vascular
remodeling. Human vascular SMCs in restenotic lesions
exhibit augmented responses to p53 [10], and arterial p53
inactivation after human cytomegalovirus infection might
contribute to coronary restenosis [11,12]. Moreover, p53 is
overexpressed, but not mutated, in human atherosclerotic
tissue [13], and expression studies in human endarterectomy
specimens suggested a role for p53 as a negative regulator of
neointimal thickening [14,15]. In line with this notion, gain-
and loss-of-function studies have causally linked p53 and
fibro-proliferative vascular disease. First, both global and
hematopoietic cell-specific p53 deficiency aggravates ather-
oma progression in murine models of diet-induced athero-
sclerosis [16–19]. Likewise, p53-null mice exhibit
accelerated neointimal thickening induced by vein grafting
[20], external vascular cuff placement [21], and mechanical
denudation [22]. Second, intraluminal antisense p53 oligo-
deoxynucleotide transfection into intact rat carotid artery
promotes vascular SMC growth [23], and p53 gene transfer
attenuates neointimal thickening in balloon-injured rat and
rabbit carotid artery [24,25], porcine interposition saphenous
vein grafts [26], and organ cultures of human saphenous vein
[27]. Notably, adenovirus-mediated p53 transfer to pre-
established atheromas induced by implantation of a perivas-
cular collar promoted vulnerability to plaque rupture [28].
While the mentioned studies have firmly established
that endogenous and ectopically expressed p53 limit neo-
intimal thickening, the role of p53 on neointimal cell pro-
liferation and apoptosis is controversial (see Discussion).
Moreover, none of the studies examined the consequences of
heightening p53 function on diet-induced atherosclerosis.
We have previously engineered a p53 transgene that behaves
as a functional replica of the endogenous p53 gene whenexpressed in p53-null mice [29]. Compared with controls,
Super-p53 transgenic mice exhibited an enhanced DNA
damage response and protection from cancer. Remarkably, in
contrast to the early ageing phenotype observed in transgenic
mice overexpressing deregulated p53 [30] or its naturally
occurring N-terminally truncated p44 variant [31], Super-
p53 mice age normally [29]. Thus, cancer resistance can
be enhanced by a simple genetic modification and in the
absence of undesirable effects. In this study, we crossed
atherosclerosis-prone apoE-KO [32] and Super-p53 [29]
mice to generate doubly mutant Super-p53/apoE-KO mice
and apoE-KO littermates. We have examined these animals
to investigate the effects of heightening p53 function in the
setting of atherosclerosis and mechanical injury of the vessel
wall.
2. Materials and methods
2.1. Mice and diets
The investigation conforms with the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health. apoE-KO (C57BL6/J, Charles
River) and Super-p53 (C57BL6/J, tg/tg carrying two extra
copies of the p53 transgene) [29] mice were mated. The
resulting heterozygous F1 was crossed with apoE-KO mice
to obtain apoE-KO mice with or without one extra p53 allele
(Super-p53/apoE-KO and apoE-KO, respectively).
Mice for spontaneous atherosclerosis and mechanical in-
jury were kept on standard chow (catalog number 2014,
Harlan Interfauna, Spain). For diet-induced atherosclerosis,
mice received standard chow for 2 months and then were
switched to high-fat diet (12.8% fat, 1.25% cholesterol, 0.5%
sodium cholate, catalog #S4892-S010, Ssniff, Germany).
Blood was withdrawn from the retroorbital plexus to mea-
sure plasma cholesterol (Kit 1: Infinity Cholesterol liquid
stable reagent, Iberdiagnóstica, Spain; Kit 2: Cholesterol
MR, Linear Chemicals, Spain). Mice were euthanized with
ether.
2.2. Immunohistopathological characterization of
neointimal lesions
For atherosclerosis studies, aortas were washed in situ
with PBS and fixed with freshly prepared 4% paraformal-
dehyde/PBS. The heart, pulmonary artery and aorta were
extracted, and fixation continued for 22–26 h at 4 °C.
Characterization of neointimal lesions was carried out by an
investigator who was blinded to genotype. The extent of
aortic atherosclerosis was determined as the intima-to-media
ratio (I/M) in hematoxylin/eosin-stained 3-μm cross-sections
(obtained from three different zones of the ascending aorta
separated ~30 μm, starting at the end of the aortic valve), or
by en face Oil Red O staining (0.2% in 80% MeOH)
(SIGMA), essentially as described before [33]. Images were
captured with an Olympus CAMEDIA C5060 digital camera
805S.M. Sanz-González et al. / Cardiovascular Research 75 (2007) 803–812mounted on a Zeiss Axiolab stereomicroscope. No differ-
ences in atheroma size were observed between males and
females of the same genotype.
For the mechanical injury model, mice were anesthetized
with Forane and underwent bilateral endoluminal injury to
the common femoral artery by passing 3 times a 0.25 mm-
diameter angioplasty guidewire as described previously [34].
Buprex was administered subcutaneously for post-operative
analgesia. Seams, ulcers and scars suggesting limb ischemia
were controlled daily. One apoE-KO mouse was sacrificed
during the post-operative period because it developed severe
foot ischemia. At 2 days and 4 weeks post-injury, mice were
killed and perfused in situ with 5 mL of PBS followed by
10 mL of freshly prepared 4% paraformaldehyde/PBS using
a peristaltic pump at approximately 1 mL/min. Both hind
limbs and pelvis were isolated in block and fixation con-
tinued for 24–28 h. Specimens were decalcified for 24 h at
room temperature with mild shaking in Osteodec (Bio-
Optica). After washes with PBS, transverse segments (ap-
proximately 2-mm thick) were cut at the level of the injury,
embedded in paraffin, and 5-μm cross-sections were ob-
tained throughout the injured segment. Specimens wereFig. 1. In vitro studies of p53 functionality. BMD/macrophages and FMSCs were
untreated or subjected to UV light (20 J/m2). Results represent the percentage of s
blot analysis of tubulin and p21 in primary FSMCs. Cells were maintained in 2
experiments. The numbers below the blots correspond to the p21/tubulin ratio es
surviving FSMCs 24 h after UV-irradiation (120 J/m2). (D) FSMCs were serum-sta
50 μM BrdU.hydrated and images captured with a Leica TCS/SP2 con-
focal microscope using the 488 nm argon laser to visualize
internal and external elastic lamina autofluorescence. Only
sections showing both the external and internal elastic lami-
na were used to quantify intimal, medial and luminal areas
(Leica LCS Lite software). Results for each artery represent
the average of all the measurements obtained from 3–5
different injured regions.
Immunohistopathological examination of neointimal
lesions included quantification of lesion cellularity (hema-
toxylin/eosin staining), cell proliferation (Ki67 and PCNA
immunoreactivity), apoptosis (Apoptag kit, caspase 3 immu-
noreactivity), and macrophage content (Mac3 immunoreac-
tivity). Details on these studies can be found in Supplemental
material.
2.3. Cell culture studies
Murine femoral SMCs (FSMCs) and bone marrow-
derived macrophages (BMD/macrophages) were obtained
essentially as described elsewhere [35,36] (see Supplemen-
tary material).obtained from wild-type and Super-p53 mice. (A) BMD/macrophages were
ub-G0/G1 cells relative to its non-irradiated control (=100%). (B) Western
0% FBS/DMEM/Fungizone. Blots are representative of two independent
timated by densitometric analysis (relative to wild-type). (C) Percentage of
rved and restimulated for 24 h with 10 ng/mL PDGF-BB in the presence of
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DTo evaluate cellular responses to UV light, BMD/macro-
phages and FSMCs were irradiated at 20 J/m2 and 120 J/m2,
respectively. BMD/macrophages were stained with propidium
iodide to determine the percentage of sub-G0/G1 cells
(FACSCanto flow cytometer, Becton Dickinson), and FSMCs
were counted 24 h after irradiation to quantify cell survival.
5′-bromodeoxyuridine (BrdU) incorporation was used
for cell proliferation studies. Serum-starved FSMCs (0.5%
FBS/DMEM/Fungizone, 3 days) were restimulated for 24 h
with 10 ng/mL PDGF-BB in the presence of 50 μM BrdU.
BMD/macrophages differentiated on DMEM containing
10% FBS/10% L929 cell-conditioned medium [36] were
switched for 6 h to 10% FBS with or without 0.5 μg/mL LPS
in the presence of 50 μM BrdU. Cells were fixed with 4%
paraformaldehyde/PBS, washed with PBS and incubated for
30 min with 0.5% Triton X100/2N HCl. Cells were washed
first with PBS and then with 122 mM Na2B4O7/32 mM
KH2PO4. After 30 min incubation with 3% H2O2/10%
methanol to inactivate endogenous peroxidase, cells were
blocked with 5% horse serum and BrdU incorporation
was visualized using anti-BrdU-biotinylated antibody
(Zymed, 1/50, 1 h, room temperature) and diaminobenzidine
substrate kit (Serotec).Fig. 2. Gain of p53 function does no affect the size of diet-induced atheromas within
7 weeks. (A) Plasma cholesterol level was measured using kit 1 in 5 males of each
genotypes were not significant. (B) Body weight was measured in 9 females/9
genotype, body weights at all fat-feeding times were significantly increased versu
significant. (C) Atherosclerosis was quantified as the I/M ratio in hematoxylin/eos
starting close to the aortic valves and separated by ∼30 μm. Representative photom
the media and the neointimal lesion. The bar represents 250 μm. Statistically sign
region I; †, pb0.02 and ††, pb0.003, versus region II). Differences between geno2.4. Western blot analysis
FSMC whole lysates were prepared in ice-cold 50 mM
HEPES (pH 7.5), 150 mM NaCl, 2.5 mM EGTA, 10 mM β-
glycerolphosphate, 10% glycerol, 0.1% Tween 20, 0.1 mM
NaVO3, 1 mM DTT, supplemented with protease inhibitor
Complete Mini cocktail (Roche Diagnostics). Lysates were
centrifuged at 14,000 rpm for 20 min (4 °C) and protein
concentration in the supernatants was determined using the
Bradford assay (BioRad Laboratories). Proteins (50 μg) were
separated onto 15% SDS-polyacrylamide gels and Western
blot analysis was carried out using anti-p21 (1/200, WA-1
clone, ref. 11-338, EXBIO) and anti-tubulin (1/200, sc-8035,
Santa Cruz) antibodies. Relative protein level was deter-
mined by densitometry using the MetaMorph software
(Universal Imaging Corporation).
2.5. Statistical analysis
Results are reported as mean±SEM. In experiments with
two groups, differences were evaluated using a 2-tail, un-
paired t-test. Otherwise, differences were evaluated using
ANOVA and Fisher's post-hoc test (Statview, SAS institute,the ascending aorta. Two-month-old mice received the high-fat diet for up to
genotype. ⁎, pb0.0001 versus pre-diet same genotype. Differences between
males (apoE-KO) and 8 females/5 males (Super-p53/apoE-KO). For each
s pre-diet values (at least pb0.04). Differences between genotypes were not
in-stained cross-sections from three different regions of the ascending aorta
icrographs are shown. The discontinuous line marks the boundaries between
ificant differences between regions (same genotype): ⁎, pb0.00035 versus
types were not significant.
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cally significant at pb0.05.
3. Results
3.1. p53 transgene functionality
We first examined the functionality of the p53 transgene
in BMD/macrophages and FMSCs in culture. Both when
examined at 8 and 16 h post-UV irradiation, Super-p53
BMD/macrophages elicited a stronger apoptotic response
than control cells from apoE-KO mice (Fig. 1A). Consistent
with the notion that p21 is a direct transcriptional target of
p53, its expression was increased by ∼2-fold in Super-p53
FSMC cultures compared with wild-type controls (Fig. 1B).
Moreover, both cell survival after UV irradiation (Fig. 1C)
and PDGF-BB-dependent proliferation were signifi-
cantly reduced in Super-p53 FSMCs (Fig. 1D). Thus, in
line with previous studies [29], Super-p53 macrophages and
FMSCs harbouring one extra p53 allele exhibit p53 gain-of-
function.Fig. 3. Gain of p53 function does not affect the size of diet-induced and spontaneou
month-old mice received the atherogenic diet for 5 weeks. (A) Plasma cholestero
pb0.0001 versus pre-diet same genotype. Differences between genotypes were
regimen or genotype (apoE-KO: 8 females/4 males; Super-p53/apoE-KO: 11 fem
stained with Oil Red O as the ratio of total lesion area (red staining) versus total are
C. A representative aorta from each gender and genotype is shown in C and D. T
between aortic arch and thoracic aorta. The discontinuous black lines in the graph3.2. Heightening p53 function has no effect on the extent of
diet-induced and spontaneous atherosclerosis
The apoE-KO mouse spontaneously develops hypercho-
lesterolemia and complex atherosclerotic lesions and these
processes can be accelerated by a high-fat cholesterol-rich
diet [32]. We first compared atherosclerotic lesion size in
apoE-KO and Super-p53/apoE-KO mice fed an atherogenic
diet for 7 and 5 weeks (Figs. 2 and 3, respectively). The
severity of hypercholesterolemia induced by fat feeding was
not affected by the p53 transgene (Figs. 2A, 3A). Likewise,
body weight was indistinguishable in apoE-KO and Super-
p53/apoE-KO mice under all conditions studied (Figs. 2B,
3B). As shown in Fig. 2C, quantification of the I/M in cross-
sections from three different zones (I, II, III) of the ascending
aorta of mice fed the fat diet for 7 weeks revealed diminished
atherosclerosis as specimens were farther from the aortic
valve (I/MIN I/MIIN I/MIII). However, no statistically signif-
icant differences were observed in none of the regions under
study when comparing apoE-KO and Super-p53/apoE-KO
mice. Examination of the pulmonary artery in the samesly formed atheromas within the aortic arch and thoracic aorta. (A–C) Two-
l level was measured using kit 2 in 3 females/3 males of each genotype. ⁎,
not significant. (B) Body weight was not significantly affected by dietary
ales/9 males). (C) Atherosclerosis was quantified in whole mounted aorta
a. (D) Spontaneous atherosclerosis in 6-month-old mice was quantified as in
he discontinuous black lines across photomicrographs mark the separation
s indicate the mean relative lesion size for each group.
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Fig. 4. Gain of p53 function reduces neointimal thickening in mechanically injured femoral arteries. Four five-month-old female mice underwent bilateral
endoluminal injury to the common femoral artery and were sacrificed 4 weeks post-surgery. Images of femoral artery cross-sections were captured with a
confocal microscope to determine the I/M ratio and percentage of luminal stenosis. Only sections showing both the external (arrow) and internal (arrowhead)
elastic lamina were analyzed. The photomicrographs show representative specimens.
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 specimens also revealed similar I/M in both groups of
mice (not shown). Likewise, Oil Red O staining of whole-
mounted aorta revealed no statistically significant differ-
ences in atheroma extent within the aortic arch and thoracic
regions of apoE-KO and Super-p53/apoE-KO mice fed the
high-fat diet for 5 weeks (Fig. 3C).Fig. 5. Gain of p53 function does not affect proliferation, apoptosis, cellularity, and
received the atherogenic diet for 7 weeks. Studies were carried out in cross-sections
estimated as Ki67 immunoreactivity. (B) Apoptosis, determined with the Apoptag
sections. (D) Macrophage content, determined as Mac-3 immunoreactivity.We also analyzed the development of spontaneous athe-
rosclerosis in a group of 6-month-old mice that had been
always fed control chow. In agreement with our results in fat-
fed mice, plasma cholesterol (not shown) and the size of
atheromas within the aortic arch and thoracic aorta were
indistinguishable between apoE-KO and Super-p53/apoE-macrophage content in aortic atheromas induced by high-fat feeding. Mice
from region I of the ascending aorta (see Fig. 2C). (A) Cellular proliferation,
kit. (C) Lesion cellularity determined in hematoxylin/eosin-stained cross-
n M
ay 29, 2016
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revealed no differences in spontaneously formed aortic
atheromas (not shown). Collectively, these studies demon-
strate that increasing p53 function does not attenuate neither
diet-induced (up to 7 weeks of fat feeding) nor spontane-
ously formed atheromas in apoE-KO mice.
3.3. Neointimal thickening is reduced in mechanically
injured femoral artery of Super-p53/apoE-KO mice
Using a femoral artery model of endoluminal mechanical
injury [34], we found that both the I/M and the percentage of
luminal stenosis were significantly attenuated in Super-p53/
apoE-KO compared to apoE-KO mice when these para-
meters were examined 4 weeks post-injury (Fig. 4).
3.4. Immunohistopathological characterization of neointi-
mal lesions
Neointimal cell proliferation and apoptotic cell death are a
hallmark of atherosclerosis and restenosis [8]. The net bal-
ance between these antagonistic processes is a major deter-
minant of cell number within the neointimal lesion, thus
influencing its size, composition and stability. Since p53 is a
key regulator of cell proliferation and apoptosis, we soughtFig. 6. Effect of extra p53 dosage on arterial cell proliferation and apoptosis in m
denudation and cross-sections were analyzed 2 days and 4 weeks post-injury. Pro
caspase-3 immunostaining (B) or Apoptag kit (D).to examine these processes in the arterial wall of apoE-KO
and Super-p53/apoE-KO mice.
For diet-induced atherosclerosis, cross-sections of the
ascending aorta from mice fed the high-fat diet for 7 weeks
were examined for Ki67 immunoreactivity and the Apoptag
kit to estimate cell proliferation and apoptosis, respectively.
Neointimal proliferation (Fig. 5A) and apoptosis (Fig. 5B)
were unaffected by the p53 transgene. Comparatively, Ki67
immunoreactivity and apoptosis were very scant within the
media (not shown). Neointimal cellularity (Fig. 5C) and
macrophage content (Fig. 5D) were also similar when com-
paring atheromas from fat-fed apoE-KO and Super-p53/
apoE-KO mice.
Cellular proliferation in mechanically injured femoral
arteries of apoE-KO and Super-p53/apoE-KO mice was
examined by PCNA-immunostaining because the decalcifi-
cation protocol employed for tissue sectioning drastically
hindered Ki67 immunoreactivity. We examined post-injury
time points preceding neointimal thickening (2 days, not
shown) and when neointimal lesions were prominent
(4 weeks, confer Fig. 4). At 2 days, the media consisted
mostly of smooth muscle α-actin-immunoreactive cells in
both groups of mice and macrophage-specific Mac-3 protein
was undetectable (not shown). Whereas medial PCNA
immunoreactivity was significantly reduced in Super-p53/echanically injured femoral artery. Mice were subjected to femoral artery
liferation was assessed by PCNA immunostaining (A, C) and apoptosis by
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 apoE-KO mice (Fig. 6A), no significant differences were
seen in the number of apoptotic cells (Fig. 6B). At 4 weeks
post-injury, medial and neointimal proliferation (Fig. 6C)
and apoptosis (Fig. 6D) were unaffected by the p53
transgene.
4. Discussion
Studies in p53-null mice have demonstrated that endog-
enous p53 expression limits neointimal thickening induced
by high-fat feeding [16–19], vein grafting [20], perivascular
cuff placement [21], and mechanical denudation [22]. In line
with these findings, transient p53 gene transfer attenuated
neointimal lesion formation in balloon-injured rat and rabbit
carotid artery [24,25], in porcine interposition vein grafts
[26], and in human saphenous vein organ cultures [27].
Taking advantage of the availability of atherosclerosis-prone
apoE-KO mice [32] and Super-p53 transgenic mice carrying
one additional p53 allele that reproduces the normal expres-
sion and regulation of the endogenous p53 gene [29], here we
assessed whether heightening p53 function can reduce
atherosclerosis and mechanically induced neointimal thick-
ening.We observed increased p53 function in Super-p53 cells
in culture. First, apoptosis was augmented in UV-irradiated
macrophages harboring the p53 transgene (Fig. 1A). Second,
primary cultures of Super-p53 FSMCs exhibited increased
expression of p21 (Fig. 1B), a direct target of p53, diminished
cell survival after UV-irradiation (Fig. 1C), and reduced
PDGF-BB-induced proliferation (Fig. 1D). However, height-
ening p53 function did not attenuate atherosclerosis within
the ascending aorta, aortic arch, thoracic aorta and pulmonary
artery of mice fed the high-fat diet for 5 and 7 weeks
(Figs. 2C, 3C, and data not shown). Likewise, spontaneously
formed aortic atheromas exhibited similar size in apoE-KO
and Super-p53/apoE-KO mice fed standard chow (Fig. 3D).
In contrast, neointimal thickening was attenuated in mechan-
ically injured femoral arteries of Super-p53/apoE-KO com-
pared with apoE-KOmice (Fig. 4). Likewise, Super-p53mice
are significantly protected from cancer [29]. Thus, p53 gain-
of-function attenuates the progression of highly proliferative
disorders (e.g., cancer and mechanically induced neointimal
hyperplasia), yet it is ineffective against atherosclerosis, a
disease characterized by lower proliferative activity com-
pared with restenosis. Of note in this regard, other significant
differences exist in the mechanisms underlying neointimal
formation in the setting of mechanically induced vascular
injury and native atherosclerosis. For instance, it would be
interesting to assess whether p53 gain-of-function affects
differentially the production of cytokines and growth factors
by de-differentiated SMCs in atherosclerotic lesions and
mechanically injured vessels.
Unbalanced cell proliferation and/or apoptosis may
underlie the consequences of altering p53 homeostasis on
mechanically induced neointimal thickening. Adenovirus-
mediated p53 gene transfer to the rat carotid artery promotes
medial cell apoptosis 2 days post-angioplasty beforeneointimal lesions are formed [37]. On the other hand,
p53-null mice display increased proliferation and decreased
apoptosis in both medial and neointimal femoral artery cells
at 2 weeks post-injury, but rapid (4 h post-injury) and late
(4 weeks post-injury) apoptosis were unaffected as compared
to wild-type controls [22]. We found significantly reduced
medial cell proliferation in femoral arteries of Super-p53-
apoE-KO mice compared with apoE-KO controls at 2 days
post-injury (Fig. 6A); however, the number of medial apo-
ptotic cells was similar in both groups (Fig. 6B). At 4 weeks
post-injury, we found no differences in neointimal and me-
dial cell proliferation and apoptosis when comparing apoE-
KO and Super-p53/apoE-KO mice (Fig. 6C, D). Thus,
inhibition of medial cell proliferation at early time points
after mechanical injury may contribute to reduced neointimal
thickening in the femoral artery of Super-p53/apoE-KO
mice.
Studies in apoE-KO, low-density lipoprotein receptor
(LDLR)-KO and apoE∗3-Leiden transgenic mice have
shown that global and macrophage-specific p53 deficiency
accelerates diet-induced aortic atherosclerosis [16–18].
Subsequently, Mercer et al. [19] found that p53 genetic
disruption aggravates atherosclerosis in the aorta but not in
the brachiocephalic artery of apoE-KO mice; however,
transplant of p53 wild-type/apoE-KO bone marrow to p53/
apoE doubly deficient mice reduced aortic plaque formation
in brachiocephalic plaques [19]. Collectively, these studies
demonstrate site and cell-type specificity in the effects of p53
on atheroma progression. We found no statistically signif-
icant differences in the size of diet-induced (5 and 7 weeks of
high-fat feeding) and spontaneously formed aortic atheromas
in Super-p53/apoE-KO compared with apoE-KO mice
(Figs. 2C, 3C, D). This lack of atheroprotection coincided
with similar proliferative and apoptotic activity, cellularity
and macrophage content in established atheromas of fat-fed
mice of both genotypes (Fig. 5). Given that macrophages are
the predominant cell type in atherosclerotic lesions of apoE-
KO mice, it is noteworthy that de novo DNA synthesis was
undistinguishable in cultures of mitogen-induced wild-type
and Super-p53 BMD/macrophages (Fig. S1A). On the other
hand, uptake of modified LDLs by p53-null [19] and Super-
p53 (Fig. S1B) peritoneal macrophages was unaffected
compared to wild-type controls. Thus, two key events during
atherosclerosis in apoE-KO mice (e.g., macrophage prolif-
eration and LDL uptake) seem to be independent of p53
expression. It remains to be determined whether p53 plays
any role on additional cellular processes which modulate
atherosclerosis development (e.g., leukocyte recruitment,
extracellular matrix formation, production of pro- and anti-
inflammatory cytokines/chemokines). The role of p53 in
plaque stability also remains uncertain. On the one hand,
transplantation of p53-deficient bone marrow into apoE∗3-
Leiden [17] or LDLR-KO [18] mice led to higher aortic
necrotic index and diminished aortic neointimal collagen
content, respectively, suggesting that macrophage-specific
p53 disruption promotes plaque instability. However, in
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 apoE-KO mice, transluminal adenovirus-mediated p53 gene
transfer into carotid artery atheromas induced by perivas-
cular collar placement also led to more vulnerable plaques,
as revealed by lower collagen content [28]. We found no
statistically significant differences in collagen content when
comparing aortic atheromas and mechanically injured
femoral arteries of apoE-KO and Super-p53/apoE-KO mice
(Fig. S2). Additional studies are thus warranted to elucidate
the mechanisms by which p53 loss- and gain-of-function
affect differently the stability of neointimal lesions in various
vascular beds subjected to distinct forms of damage (e.g.,
hypercholesterolemia, perivascular collar deployment, me-
chanical denudation).
The role of endogenous p53 in the control of neointimal
proliferation and apoptosis in the context of murine
atherosclerosis has hitherto remained subject to controversy.
Two studies suggest that p53 deficiency leads to increased
neointimal proliferation without significantly affecting apo-
ptosis (although a tendency towards more apoptosis was seen
in one study) [16,18], and a third study disclosed a tendency
towards reduced apoptosis but unaffected cell proliferation
[17]. None of these studies identified the lineage of the
growing/dying cells. Subsequently, Mercer et al. [19]
reported that p53 disruption in brachiocephalic plaques of
apoE-KO mice significantly increases neointimal cell
proliferation and reduces apoptosis. Although most neointi-
mal proliferating cells were monocyte/macrophages (92–
97%), neointimal apoptotic cells were both macrophages
(75%) and SMCs (25%). In tissue culture experiments, these
authors observed that endogenous p53 promotes peritoneal
macrophage apoptosis but attenuates apoptotic death of aortic
SMCs and bone marrow stromal cell, which can transdiffer-
entiate into cells expressing SMC-specific makers [38]. We
found reduced viability of in vitro UV-irradiated BMD/
macrophages (Fig. 1A) and FSMCs (Fig. 1C) carrying the
p53 transgene. However, p53 gain-of-function appears to
have cell-type specific effects on proliferation, since BrdU
incorporation was reduced in Super-p53 FMSCs (Fig. 1D)
but not in Super-p53 BMD/macrophages (Fig. S1A). Thus,
the consequences of both p53 disruption and gain-of-function
on neointimal cell proliferation and cell death seem to depend
upon the cell type and vascular bed under study.
In summary, we have demonstrated that, in the absence of
undesirable effects, increased p53 gene dosage in apoE-KO
mice reduces neointimal thickening induced by mechanical
vessel denudation. In contrast, this genetic manipulation did
not affect either diet-induced or spontaneous atherosclerosis
in several vascular beds (e.g., ascending aorta, aortic arch,
thoracic aorta, and pulmonary artery). It remains to be
determined whether heightening p53 function beyond that
achieved in Super-p53/apoE-KO would protect from ath-
erosclerosis. This could be achieved by generating apoE-KO
mice carrying ≥2 additional p53 alleles, or inhibiting the
Mdm2/p53 interaction with “AP peptide”, nutlins, RITA,
or inhibitors of the E3 ubiquitin ligase activity of Mdm2,
a negative regulator of p53 that can both prevent effectivep53-dependent transcriptional activation and target it for
proteasomal degradation [9,39]. However, the potential
benefits of these strategies may be hindered by noxious
effects. First, transgenic mice with hyperactivated p53, or its
naturally occurring N-terminal truncated isoform p44, exhib-
it symptoms of premature ageing (e.g., reduced longevity,
osteoporosis, generalized organ atrophy and a diminished
stress tolerance) [30,31], perhaps because p53 in these mice
has an altered transcriptional program rather than an overall
increase in activity [9,39]. Second, indiscriminate p53 acti-
vation in normal cells upon drug-based Mdm2 inactivation
may lead to fatal pathologies, as shown in Mdm2-null mice
[40]. Whilst these potential side effects might preclude the
use of prophylactic measures based on p53 hyperactivation
for the treatment of atherosclerosis, a chronic disease that
requires long-term treatment, restenosis might be amenable
for these strategies because treatment might be limited to
the first few months after revascularization when neointimal
hyperplasia typically occurs.
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